India’s first mRNA vaccine against Covid-19 from Gennova gets DCGI approval
Gennova's vaccine will be available for adults above 18 years of age. It will be a two-dose vaccine that will be administered intramuscularly at 28 days apart
Gennova's vaccine will be available for adults above 18 years of age. It will be a two-dose vaccine that will be administered intramuscularly at 28 days apart
